相关实验视频

Updated: Aug 10, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

一个器官类型的人类黑色素瘤在皮肤中的模型作为一个体外工具来测试Vγ9Vδ2-T细胞基础免疫疗法

E Michielon^1,2,3, L A King^2,3,4, T Waaijman^1,2

¹Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center Location Vrije Universiteit Amsterdam, Amsterdam.

Immuno-oncology technology

|September 2, 2024

概括

在3D黑色素瘤模型中,效应器Vγ9Vδ2-T细胞显示活力和抗瘤功能. 为了在癌症免疫治疗中显著消除瘤细胞,需要进一步优化.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

晚期黑色素瘤仍然是癌症免疫疗法的重大挑战.
探索新的治疗策略对于改善患者的治疗结果至关重要.

研究的目的:

为了研究效应器Vγ9Vδ2-T细胞的免疫治疗潜力.
为了评估Vγ9Vδ2-T细胞功能在一个3D人体器官类型的黑色素瘤在皮肤 (Mel-RhS) 模型.

主要方法:

通过皮内注射将Vγ9Vδ2-T细胞引入Mel-RhS模型.
细胞活力,迁移和与黑色素瘤细胞的相互作用在3天内被评估.
分析了T细胞激活标志物和与黑色素瘤相关的氏素硫酸蛋白糖 (MCSP) 相互作用.

主要成果:

Vγ9Vδ2-T细胞保持活力,并在瘤微环境中表现出迁移能力.
装饰着MCSP的Vγ9Vδ2-T细胞显示出增强的激活状态,表明与黑色素瘤细胞的相互作用.
观察到有限的瘤细胞消除,这表明需要增强T细胞受体介导的信号传递.

结论:

3D Mel-RhS模型适用于评估基于T细胞的疗法.
由于Vγ9Vδ2-T细胞的活力和功能活性,它们显示出黑色素瘤免疫治疗的潜力.
需要进一步的研究来优化Vγ9Vδ2-T细胞介导的瘤消除.

关键词:

在Vγ9Vδ2-T细胞中.免疫疗法免疫疗法在体外重建的人体皮肤.黑色素瘤是一种黑色素瘤.瘤微环境是一个微环境.

更多相关视频

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

相关概念视频

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...